Novo Nordisk A/S (NVO) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Technical Indicators
|
|
|
Bearish (14)
Neutral (8)
Bullish (5)
Performance
NVO ROI
% from 52W High
52W Low: $96.21
12 Dec 2023
52W High: $146.91
25 Jun 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
